Literature DB >> 28394341

Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment.

B Joseph, P Marchetti, P Formstecher, G Kroemer, R Lewensohn, B Zhivotovsky.   

Abstract

This corrects the article DOI: 10.1038/sj.onc.1205018.

Entities:  

Year:  2017        PMID： 28394341     DOI： 10.1038/onc.2017.78

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  3 in total

Review 1.  Progress in Isoindolone Alkaloid Derivatives from Marine Microorganism: Pharmacology, Preparation, and Mechanism.

Authors:  Sijin Hang; Hui Chen; Wenhui Wu; Shiyi Wang; Yiwen Fang; Ruilong Sheng; Qidong Tu; Ruihua Guo
Journal:  Mar Drugs       Date:  2022-06-20       Impact factor: 6.085

Review 2.  Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.

Authors:  Tingting Wen; Lei Song; Shucheng Hua
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452

3.  FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer via Elevation of ROS Mediated by the EGFR/PI3K/Akt/mTOR Pathway.

Authors:  Shike Yan; Bing Zhang; Jingwen Feng; Haigang Wu; Namin Duan; Yamin Zhu; Yueliang Zhao; Shuang Shen; Kai Zhang; Wenhui Wu; Ning Liu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.